Age-Related Changes in Brain and Pituitary 5ce-Reductase With Finasteride (Proscar) Treatment
ثبت نشده
چکیده
LEPHART, E. D. Age-related changes in brain and pituitary 5c~-reductase with finasteride (Proscar) treatment. NEUROBIOL AGING 16(4) 647-650, 1995.-Finasteride (Proscar), a 5u-reductase inhibitor, was administered with or without 5u-dihydrotestosterone (DHT) in juvenile (28), peripubertal (48), or young adult (68-day-old) male rats. Luteinizing hormone (LH) levels and ventral prostate (VP) weights monitored the efficacy of the treatments. For each postnatal day tested, LH hormone levels were not significantly altered by finasteride, suggesting that 5a-reductase inhibition does not modulate LH in male rats using this protocol. Finasteride plus DHT treatment significantly decreased LH levels. Conversely, VP weights were significantly decreased in finasteride-treated animals while finasteride plus DHT treatment significantly increased VP values. Finasteride plus DHT treatment significantly decreased pituitary, but not brain, 5a-reductase for each postnatal day tested. In finasteride-treated animals, hypothalamic and pituitary 5u-reductase were significantly inhibited in young adult animals, whereas the activities were not altered in juvenile or peripubertal male rats. These data suggest that a different mechanism may regulate 5c~-reductase with the aging of the central nervous system and pituitary.
منابع مشابه
Benign prostatic hyperplasia (BPH) management in the primary care setting.
Benign prostate hyperplasia (BPH) occurs in up to 50% of men by age 50, and the incidence increases with age. This common clinical problem is diagnosed by history, including the International Prostate Symptom Score (IPSS) questionnaire, and physical examination by digital rectal examination (DRE). Initial management for BPH includes lifestyle modification, and smooth muscle relaxant alpha blo...
متن کاملMale breast cancer during finasteride therapy.
Male breast cancer is an uncommon disease, with an estimated incidence of one case per 100 000 man-years (1). Conditions that result in relative estrogen excess or lack of androgen are associated with an increased risk of breast cancer in both women (2) and men (3). An example of increased rates of male breast cancer associated with increased estrogen-to-testosterone ratios can be seen in men w...
متن کاملHypopituitarism in adult patients with non-pituitary brain cancer following radiation therapy
Introduction: The purpose and our novelty of the current study were to evaluate the HPA function in adult survivors of primary non-pituitary brain tumors and its association with treatment-related factors such as received dose to the organs at risk, age at irradiation, surgery, and adjuvant chemotherapy in patients treated with RT for brain tumors. Moreover, it aimed to achie...
متن کاملThe impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
BACKGROUND Previously, we studied the effect of finasteride- or dutasteride-containing diets in male C57BL/6 TRAMP x FVB mice. Pre (6 weeks of age) and post (12 weeks of age) groups received finasteride or dutasteride to determine the efficacy of these pharmaceuticals on prostate cancer (PCa) development in male C57BL/6 TRAMP x FVB mice. Post-Dutasteride treatment was more effective than Pre-Du...
متن کاملFinasteride induced depression: a prospective study
BACKGROUND Finasteride is a competitive inhibitor of 5 alpha-reductase enzyme, and is used for treatment of benign prostatic hyperplasia and androgenetic alopecia. Animal studies have shown that finasteride might induce behavioral changes. Additionally, some cases of finasteride-induced depression have been reported in humans. The purpose of this study was to examine whether depressive symptoms...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2003